Targeting ROS in cancer: rationale and strategies

C Glorieux, S Liu, D Trachootham… - Nature Reviews Drug …, 2024 - nature.com
Reactive oxygen species (ROS) in biological systems are transient but essential molecules
that are generated and eliminated by a complex set of delicately balanced molecular …

Engineering dendritic cell vaccines to improve cancer immunotherapy

CR Perez, M De Palma - Nature communications, 2019 - nature.com
At the interface between the innate and adaptive immune system, dendritic cells (DCs) play
key roles in tumour immunity and hold a hitherto unrealized potential for cancer …

The Role of Macrophages in Staphylococcus aureus Infection

GR Pidwill, JF Gibson, J Cole, SA Renshaw… - Frontiers in …, 2021 - frontiersin.org
Staphylococcus aureus is a member of the human commensal microflora that exists,
apparently benignly, at multiple sites on the host. However, as an opportunist pathogen it …

Dendritic cells in cancer immunology

TL Murphy, KM Murphy - Cellular & molecular immunology, 2022 - nature.com
The clinical success of immune checkpoint therapy (ICT) has produced explosive growth in
tumor immunology research because ICT was discovered through basic studies of immune …

Many roads lead to CASM: Diverse stimuli of noncanonical autophagy share a unifying molecular mechanism

J Durgan, O Florey - Science Advances, 2022 - science.org
Autophagy is a fundamental catabolic process coordinated by a network of autophagy-
related (ATG) proteins. These ATG proteins also perform an important parallel role in …

Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing

BW MacNabb, X Chen, S Tumuluru, J Godfrey… - Immunity, 2022 - cell.com
Antigen cross-presentation, wherein dendritic cells (DCs) present exogenous antigen on
major histocompatibility class I (MHC-I) molecules, is considered the primary mechanism by …

Current concepts of antigen cross-presentation

M Embgenbroich, S Burgdorf - Frontiers in immunology, 2018 - frontiersin.org
Dendritic cells have the ability to efficiently present internalized antigens on major
histocompatibility complex (MHC) I molecules. This process is termed cross-presentation …

Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition

H Salmon, J Idoyaga, A Rahman, M Leboeuf… - Immunity, 2016 - cell.com
Large numbers of melanoma lesions develop resistance to targeted inhibition of mutant
BRAF or fail to respond to checkpoint blockade. We explored whether modulation of …

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

ML Broz, M Binnewies, B Boldajipour, AE Nelson… - Cancer cell, 2014 - cell.com
It is well understood that antigen-presenting cells (APCs) within tumors typically do not
maintain cytotoxic T cell (CTL) function, despite engaging them. Across multiple mouse …

The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens

J Canton, H Blees, CM Henry, MD Buck, O Schulz… - Nature …, 2021 - nature.com
Abstract Type 1 conventional dendritic (cDC1) cells are necessary for cross-presentation of
many viral and tumor antigens to CD8+ T cells. cDC1 cells can be identified in mice and …